Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Neurocrine Biosciences	Repligen	Denali Therapeutics	QIAGEN	Twist Bioscience
Symbol	NASDAQ:NBIX	NASDAQ:RGEN	NASDAQ:DNLI	NYSE:QGEN	NASDAQ:TWST
Price Information
Current Price	$109.91	$219.45	$68.32	$51.53	$143.53
52 Week Range	Buy	Buy	Buy	Buy	Hold
MarketRank™
Overall Score	2.1	1.5	1.1	1.5	1.2
Analysis Score	3.3	1.5	1.5	2.3	1.1
Community Score	3.6	2.6	2.5	2.3	2.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	1.7	0.8	1.7
Earnings & Valuation Score	1.9	1.9	0.0	1.9	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Hold
Consensus Price Target	$128.53	$178.25	$59.10	$56.37	$133.33
% Upside from Price Target	16.94% upside	-18.77% downside	-13.50% downside	9.39% upside	-7.10% downside
Trade Information
Market Cap	$10.20 billion	$10.87 billion	$7.75 billion	$12.17 billion	$6.58 billion
Beta	1.01	0.94	2	0.41	0.83
Average Volume	920,248	374,094	650,556	978,903	912,832
Sales & Book Value
Annual Revenue	$788.10 million	$270.24 million	$26.68 million	$1.53 billion	$90.10 million
Price / Sales	13.10	42.73	307.08	7.69	77.50
Cashflow	$0.69 per share	$1.49 per share	N/A	$2.57 per share	N/A
Price / Cash	158.60	147.51	N/A	20.07	N/A
Book Value	$6.92 per share	$20.36 per share	$4.11 per share	$11.14 per share	$7.53 per share
Price / Book	15.88	10.78	16.62	4.63	19.06
Profitability
Net Income	$37.01 million	$21.41 million	$-197,610,000.00	$-41,460,000.00	$-139,930,000.00
EPS	$0.39	$1.07	($2.07)	$1.43	($3.00)
Trailing P/E Ratio	118.18	267.62	N/A	63.62	N/A
Forward P/E Ratio	30.36	132.20	N/A	21.03	N/A
P/E Growth	N/A	4.18	N/A	1.29	N/A
Net Margins	8.96%	13.40%	-968.59%	11.18%	-155.31%
Return on Equity (ROE)	18.18%	6.58%	-39.19%	17.51%	-44.62%
Return on Assets (ROA)	9.50%	5.00%	-30.71%	8.44%	-35.49%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.21%	N/A	0.52%	N/A
Current Ratio	1.89%	13.67%	9.21%	1.46%	9.29%
Quick Ratio	1.86%	12.13%	9.21%	1.22%	8.95%
Ownership Information
Institutional Ownership Percentage	95.25%	84.33%	68.15%	43.64%	87.90%
Insider Ownership Percentage	4.30%	1.70%	19.30%	9.00%	7.00%
Miscellaneous
Employees	825	761	281	5,300	525
Shares Outstanding	93.94 million	52.62 million	119.92 million	227.75 million	48.65 million
Next Earnings Date	5/5/2021 (Estimated)	2/24/2021 (Confirmed)	2/25/2021 (Estimated)	5/5/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources